Macrolides: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
ClaireLewis (talk | contribs) No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
*Erythromycin, Clarithromycin, Azithromycin | *[[Erythromycin]], [[Clarithromycin]], [[Azithromycin]] | ||
**Community-acquired | **Community-acquired [[pneumonia]] | ||
**Mycoplasma | **[[Mycoplasma]] | ||
**Legionnaires' Disease | **[[Legionella|Legionnaires' Disease]] | ||
**Chlamydia (single dose) | **[[Chlamydia]] (single dose) | ||
**H. | **[[H. pylori]] | ||
**Traveler's diarrhea (children and pregnant women) | **[[Traveler's diarrhea]] (children and pregnant women) | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Latest revision as of 23:04, 22 September 2019
- Erythromycin, Clarithromycin, Azithromycin
- Community-acquired pneumonia
- Mycoplasma
- Legionnaires' Disease
- Chlamydia (single dose)
- H. pylori
- Traveler's diarrhea (children and pregnant women)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology